Cargando…

Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia

BACKGROUND: Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study’s aim was to investigate the importance of glucose tolerance for long-term clinical outcome in patients with acute coronary syndrome (ACS)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhl, Jeanette, Jörneskog, Gun, Wemminger, Malin, Bengtsson, Mattias, Lundman, Pia, Kalani, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574088/ https://www.ncbi.nlm.nih.gov/pubmed/26382578 http://dx.doi.org/10.1186/s12933-015-0283-3

Ejemplares similares

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
por: Östlund Papadogeorgos, Nikolaos, et al.
Publicado: (2016)

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
por: Karayiannides, Stelios, et al.
Publicado: (2021)

Improved Peripheral Perfusion During Endothelin-A Receptor Blockade in Patients With Type 2 Diabetes and Critical Limb Ischemia
por: Kalani, Majid, et al.
Publicado: (2008)

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
por: Östlund Papadogeorgos, Nikolaos, et al.
Publicado: (2009)

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
por: Ferrannini, Giulia, et al.
Publicado: (2021)

Rethinking the syndemic of tuberculosis and dysglycaemia: a Kenyan perspective on dysglycaemia as a neglected risk factor for tuberculosis
por: Kerama, Cheryl, et al.
Publicado: (2023)

Fanconi–Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia
por: Sharari, Sanaa, et al.
Publicado: (2020)

Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus
por: Fu, Zhenhong, et al.
Publicado: (2013)

Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes
por: Torffvit, Ole, et al.
Publicado: (2012)

Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting
por: Djupsjo, Catarina, et al.
Publicado: (2020)

Critical illness-induced dysglycaemia: diabetes and beyond
por: Smith, Fang Gao, et al.
Publicado: (2010)

Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia: Experiences from the randomized, controlled SOCOGAMI trial
por: Fortin, Elena, et al.
Publicado: (2023)

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry
por: Wasem, Jürgen, et al.
Publicado: (2013)

Cholecystectomy is associated with dysglycaemia: Cross‐sectional and prospective analyses
por: Sang, Miaomiao, et al.
Publicado: (2022)

Relationship between red cell distribution width and long-term mortality in patients with non-ST elevation acute coronary syndrome
por: Bekler, Adem, et al.
Publicado: (2016)

Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study
por: Jiao, Yang, et al.
Publicado: (2022)

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study
por: Zheng, Bo, et al.
Publicado: (2020)

The Effect of Dysglycaemia on Changes in Pulmonary and Aerobic Function in Cystic Fibrosis
por: Tomlinson, Owen W., et al.
Publicado: (2022)

Next Generation Sequencing (NGS) Target Approach for Undiagnosed Dysglycaemia
por: Aloi, Concetta, et al.
Publicado: (2023)

Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review
por: Sarwar, Nadeem, et al.
Publicado: (2010)

Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans
por: Nguyen, Kim A., et al.
Publicado: (2019)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61
por: Winzap, Patric, et al.
Publicado: (2019)

Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
por: Perry, Benjamin Ian, et al.
Publicado: (2019)

Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?
por: Ferrannini, Giulia, et al.
Publicado: (2020)

Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long‐term outcomes in patients with INOCA
por: Mohammed, Ayman A., et al.
Publicado: (2022)

Long‐term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography
por: Hanson, Christopher A., et al.
Publicado: (2021)

Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019)

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)
por: Leibovitz, Eyal, et al.
Publicado: (2013)

Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention
por: Liu, Xiao-Jun, et al.
Publicado: (2015)

Assessment of the performance of blood glucose monitoring systems for monitoring dysglycaemia in neonatal patients
por: Ba, Yin, et al.
Publicado: (2018)

Comparison of neurocognitive changes among newly diagnosed tuberculosis patients with and without dysglycaemia
por: Yorke, Ernest, et al.
Publicado: (2020)

Sex‐gender disparities in nonagenarians with acute coronary syndrome
por: Cepas‐Guillen, Pedro L., et al.
Publicado: (2021)

Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%
por: Ouchi, Shohei, et al.
Publicado: (2017)

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology
por: Shahim, Bahira, et al.
Publicado: (2018)

Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes
por: Okada, Kozo, et al.
Publicado: (2015)

Long-term results of transradial rotational atherectomy for heavily calcified coronary artery lesions
por: Chen, Mantian, et al.
Publicado: (2016)

J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Choi, Ik Jun, et al.
Publicado: (2021)

Predictive values of coronary artery calcium and arterial stiffness for long‐term cardiovascular events in patients with stable coronary artery disease
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
por: de Abreu, L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n6ole6rhgdd7imv08cee7huffv